Strata Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Strata Wealth Advisors's PFE Position: Q1 2026 in Review
Strata Wealth Advisors increased its Pfizer (PFE) stake by 6.2% in Q1 2026, buying an estimated $17K and bringing the position to 11,000 shares worth $309K. The position accounts for 0.08% of the portfolio, ranked #71.
Strata Wealth Advisors first reported a position in PFE in Q3 2024 and has held it in 6 quarters since. The position peaked at $402K in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Strata Wealth Advisors held 11,000 shares of Pfizer worth $309K as of Q1 2026.
- Strata Wealth Advisors bought 639 Pfizer shares in Q1 2026, an estimated $17K.
- Pfizer made up 0.08% of Strata Wealth Advisors's portfolio in Q1 2026, its #71 holding.
- Strata Wealth Advisors first reported a position in Pfizer in Q3 2024 and has held it in 6 quarters since.
- Strata Wealth Advisors's Pfizer position peaked at $402K in Q4 2024.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Strata Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.